Latest News and Press Releases
Want to stay updated on the latest news?
-
PDSB announced that Infectimune® immune response data were featured at the American Association of Immunologists’ IMMUNOLOGY2025™ Annual Meeting.
-
WATERTOWN, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader...
-
Watertown, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader...
-
Data from the BroADen Phase 1b atopic dermatitis (AD) patient trial expected to be reported in 4Q25 Completed SAD/MAD dosing in KT-621 Phase 1 healthy volunteer trial with data to be reported in June...
-
PDS Biotech announced that immune response data with a novel Infectimune® based flu vaccine will be featured at the IMMUNOLOGY2025 Annual Meeting.
-
Series C round led by Deep Track Capital with participation from additional new and existing investors Financing will fund early-to-mid-stage clinical studies for ATTO-1310 in chronic pruritus and...
-
WATERTOWN, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader...
-
LOS ANGELES, March 31, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to targeting cancer and autoimmune diseases through...
-
취리히, March 18, 2025 (GLOBE NEWSWIRE) -- 유럽 알레르기 임상 면역학회(EAACI)가 6월 13~16일 영국 글래스고 (Glasgow)에서 열리는 'EAACI 학술대회 2025' (EAACI Congress 2025)를 개최한다고 발표했다. 올해 행사의 주제는 "알레르기, 천식 및 임상 면역학의 경계를 허물다: 지속 가능한...
-
ZURICH, March 18, 2025 (GLOBE NEWSWIRE) -- Akademi Alergi dan Imunologi Klinis Eropa (European Academy of Allergy and Clinical Immunology, EAACI) dengan bangga mempersembahkan Kongres EAACI 2025,...